Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions
Cardiac Failure Review · 27.01.2025 · 11
DOI: 10.15420/cfr.2024.32 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiac Failure Review, online erschienen am 27.01.2025. Verfasst von Antonio Luca Maria Parlati und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine, Faculty of Life Sci…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Congestion in patients with heart failure (HF) predicts adverse outcomes and is a leading cause of hospitalisation. Understanding congestion mechanisms helps in HF management and underscores the importance of tailored therapies to treat vascular and tissue congestion, improving patient outcomes. In this setting, several tools are available to detect congestion. Biomarker measurement is a simple, valid and affordable method to evaluate congestion in patients with HF. Natriuretic peptides are the most widely available tool in acute and chronic HF, helping diagnosis, risk stratification and management. Novel biomarkers can potentially become reliable allies in diagnosing and monitoring patients with HF. This review aims to assess the current scientific literature on biomarkers for managing HF, evaluate their clinical utility and explore future perspectives in this field
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine, Faculty of Life Sciences and Medicine, King's College London London, UK.
- Department of Advanced Biomedical Sciences, University of Naples Federico II Naples, Italy.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Cardiology Unit, University of Palermo, University Hospital P Giaccone Palermo, Italy.
- Clinical Cardiology and Heart Failure Unit, Mediterranean Institute for Transplantation and Advanced Specialized Therapies IRCCS Palermo, Italy.
- De Gasperis Cardio Center and Transplant Center, Niguarda Hospital Milan, Italy.
- Instituto Nacional de Cardiología Ignacio Chávez Mexico City, Mexico.
Zitieren
APA
Parlati, A. L. M., Madaudo, C., Nuzzi, V., Manca, P., Gentile, P., Di Lisi, D., Jordán-Ríos, A., Shamsi, A., Manzoni, M., Sadler, M., Godino, C., Corrado, E., Paolillo, S., Novo, G., Tuttolomondo, A., Galassi, A. R., Filardi, P. P., Bromage, D., & Cannata, A. (2025). Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions. Cardiac Failure Review, 11. https://doi.org/10.15420/cfr.2024.32
Vancouver
Parlati ALM, Madaudo C, Nuzzi V, Manca P, Gentile P, Di Lisi D, et al. Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions. Cardiac Failure Review. 2025;11. doi:10.15420/cfr.2024.32
BibTeX
@article{Parlati2025,
author = {Parlati, Antonio Luca Maria and Madaudo, Cristina and Nuzzi, Vincenzo and Manca, Paolo and Gentile, Piero and Di Lisi, Daniela and Jordán-Ríos, Antonio and Shamsi, Aamir and Manzoni, Mattia and Sadler, Matthew and Godino, Cosmo and Corrado, Egle and Paolillo, Stefania and Novo, Giuseppina and Tuttolomondo, Antonino and Galassi, Alfredo Ruggero and Filardi, Pasquale Perrone and Bromage, Daniel and Cannata, Antonio},
title = {Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions},
journal = {Cardiac Failure Review},
year = {2025},
volume = {11},
doi = {10.15420/cfr.2024.32}
}
EUVIMED